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a b s t r a c t
 
 
 
 
 
 
 
 
 
A spot-on formulation combining permethrin, dinotefuran and pyriproxyfen (Vectra 3DTM
spot-on solution for dogs – one 10–25kg pipette contains 196mg dinotefuran, 1429mg
permethrin and17mgpyriproxyfen)was evaluated in adult Beagle dogs in a studydesigned
to measure its efﬁcacy to control Aedes aegypti (anti-feeding effect and mortality effect).
The trial was performed according to Animal Welfare and Good Clinical Practice.
Twelve dogs (ﬁve males and seven female, >3 years old, weighing 8.8–13.0 kg) were ran-
domly allocated to treatment groups on pre-treatment mosquito counts: six dogs served
as untreated controls, and six dogs were treated with the test formulation. Treatment con-
sisted of applying a combination formulation to deliver at least 46.6mgkg−1 permethrin,
6.40mgkg−1 dinotefuran and 0.57mgkg−1 pyriproxyfen. The combination is designed to
control ﬂeas, ticks, sand ﬂies and mosquitoes. Each dog was infested with approximately
100 adult unfed A. aegypti once before treatment (day 6) then at 1, 7, 14, 21 and 28 days
post-treatment. Counts and engorgement determination of dead and live mosquitoes were
performed after 1h exposure period. In the treated group (group A), the repellency effect of
the product based on engorgement status (anti-feeding effect), was 91.5%, 94%, 94.7%, 94%
and 87% at 1, 7, 14, 21 and 28 days post-treatment. Mortality effect or insecticidal efﬁcacy
calculated at the end of the 1-h exposure was almost identical when calculated 24h after
the 1-h exposure and remained above 93% until the end of the in-life phase. No adverse
events were observed following treatment, including observations conducted 2, 4 and 24h
after the last dog was treated.
© 2012 Elsevier B.V. Open access under CC BY-NC-ND license.Aedes aegypti is a major vector of Diroﬁlaria immitis
eartworm, the most serious mosquito-borne disease in
ogs (Apperson et al., 1989; Russell et al., 2005; Genchi
t al., 2009; Vezzani et al., 2011) and of Diroﬁlaria repens
Anyanwu et al., 2000). Diroﬁlariosis can be prevented
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ttp://dx.doi.org/10.1016/j.vetpar.2012.04.026by the use of anthelmintics such as moxidectin (Genchi
et al., 2010), ivermectin,milbemycin oxime and selamectin
(Blagburn et al., 2011). The application of a parasiticide
having an anti-feeding effect on mosquitoes can be addi-
tional help preventing the risk of Diroﬁlaria transmission
by infected mosquitoes (Haysaki and Saeki, 2009). 
 
 
 
 
 
 
 
Controlling ectoparasites (ﬂeas, ticks, sandﬂies and
mosquitoes) on pets is a constant request from owners and
a persistent issue for practitioners; as a consequence, new
products combining different active ingredients are being
 Parasito
The mosquitoes were fed on sugar–water and checked for
mortality after 24 h.
1 Medetomidine, intramuscular (IM); Dexdomitor® , PFIZER Santé ani-334 M. Franc et al. / Veterinary
developed. A formulation combining dinotefuran, perme-
thrin and pyriproxyfen (Vectra 3D) was registered in the
USA in 2007 and is indicated for the prevention and treat-
ment of ﬂeas, ticks, ﬂies and mosquitoes on dogs.
Permethrin is a well-known insecticide used for years
for the control of ectoparasites on companion animals and
farm animals (Ross et al., 1997; Machida et al., 2008).
Permethrin, as all of the pyrethroids, exerts its action
on sodium voltage-dependent channels of the parasites.
Pyrethroids modulate the conductance of the sodium ions
in these channels by increasing the duration of their open-
ing which leads to hyper-excitability and death of the
parasite (Clark and Symington, 2012).
Dinotefuran is a third-generation rapid-acting
nitroguanidine neonicotinoid insecticide exerting its
action on a unique acetylcholine receptor present in the
insect nerve synapse by mimicking the action of the
neurotransmitter (Wakita et al., 2005). Pyriproxifen used
in this combination targets the insect endocrine system
by miming the activity of the insect juvenile hormone. It
acts to stop the ﬂea life cycle by preventing development
of immature stages of ﬂeas thereby arresting the devel-
opment of ﬂea eggs, ﬂea larvae and pupae (Meola et al.,
1996; Miller et al., 1999; Murphy et al., 2009).
This study was conducted to assess the efﬁcacy of
a permethrin–dinotefuran–pyriproxyfen spot-on formula-
tion to repel and kill adult A. aegypti mosquitoes on dogs.
The study was conducted in accordance with Animal Wel-
fare and Good Clinical Practice.
1. Materials and methods
1.1. Dogs
Five males and seven female Beagle dogs (>3 years old,
healthy, weighing 8.8–13.0 kg) from the École Nationale
Vétérinaire de Toulouse (ENVT) were enrolled. Dogs had
not been exposed to ectoparasiticides for 3 months prior
to treatment and remained in good health throughout the
study. Dogs were housed individually in cages indoors with
controlled environmental conditions. Dogs were fed a com-
mercial dry dog food ration calculated to maintain the
animal in a healthy physical state. Water was available
ad libitum through automatic lickers. No concurrent med-
ication was given during the study. Dogs were managed
similarly and with due regard for their well-being. Animals
were handled in compliance with the relevant Institutional
Animal Care and with the Regional Ethics Committee for
animal experimentation.
The dogs were acclimated to study conditions for 14
days prior to treatment and were observed for general
health conditions throughout the study. On day 7, each
dog was challenged with 100 unfed adult female A. aegypti.
They were ranked according to the number of A. aegypti
biting into two groups of six (treated–untreated).1.2. Mosquito maintenance and supply
A. aegypti (Liverpool strain) originally sourced from
Milano were cultured at ENVT using a 5-week egg to adultlogy 189 (2012) 333– 337
cycle beginning July 2010. Mosquitoes were reared follow-
ing Fortin and Slocombe (1981).
1.3. Treatment
Group A dogs remained untreated, group B dogs were
treated with a permethrin, dinotefuran and pyriproxyfen
combination spot-on 1.6 ml  (dogs weighing between 4.1
and 10.0 kg) or 3.6 ml  (dogs weighing between 10.1 and
25.0 kg). For all treated animals, formulation was  applied
by parting the hair and applying the spot-on directly to
the skin: for dogs weighing less than 10.0 kg, a 1.6-ml
pipette was used with half of the dose applied between
the shoulder blades and half of the dose at the base of
the tail, for dogs weighing more than 10.1 kg, a 3.6-ml
pipette was used with one-third of the dose between the
shoulder blades, one-third of the dose at the base of the
tail, then one-third of the dose in the middle of the back
(Vectra 3DTM spot-on solution for dogs – one 10–25 kg
pipette contains 196 mg  dinotefuran, 1429 mg  permethrin
and 17 mg  pyriproxyfen). Treatment dosages were in the
range of 69–135 mg  kg−1 for permethrin, 9.5–18.5 mg kg−1
for dinotefuran and 0.84–1.64 mg  kg−1 for pyriproxyfen.
1.4. Experimental procedure
The mosquitoes challenge assessment cages
(60 cm × 40 cm × 50 cm)  were constructed from mosquito
netting mounted on a wooden frame and placed in envi-
ronmentally controlled rooms. One hundred unfed female
mosquitoes were placed in each of these 24 h before
introducing the dogs which were sedated using ketamine1
(9 mg  kg−1), medetomidine2 (4 g kg−1) and diazepam3
(5 mg  dog−1).
After 60 ± 5 min  of exposure, the dogs were care-
fully taken out of the net and examined for any dead
mosquito on their body, and then placed back in their
cage. All live mosquitoes were aspirated from each chal-
lenge net using a vacuum pump and were recorded as live
engorged or live non-engorged. All dead mosquitoes were
collected, counted and recorded as dead non-engorged
or dead engorged. During infestation, treated dogs and
control dogs were placed in separated infestation rooms
where temperature and relative humidity were maintained
between 25 ◦C and 26 ◦C and between 58% and 72%, respec-
tively. Cages and nets were thoroughly cleaned after each
mosquito challenge.
On days −6, 1, 7, 14, 21 and 28, live mosquitoes recov-
ered from individual animals at the end of exposure were
placed in separate nets and kept in the experimental room.male, 23-25 av Dr Lannelongue, 75668 Paris.
2 Ketamine, IM; Clorketam® , Laboratoire VETOQUINOL S.A. 70204 Lure
cedex.
3 Diazepam, IM;  Valium® Roche injectable, 52 Bd du parc, 92521 Neuilly
s/ Seine cedex.
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.5. Data analysis
Anti-feeding effect: For each time point after exposure,
he anti-feeding rate was evaluated for each group as
escribed below and compared to the control group:
nti-feeding rate = Total number of unengorged mos
Total number of recovered mosq
hen the anti-feeding effect (expressed in percentage) was
etermined:
ntifeeding effect = 100 × anti-feeding rate in treated
1 − anti-feed
Mortality effect: For each time point after exposure, the
ortality rate was evaluated for each group as described
elow and compared to the control group:
ortality rate = Total number of dead mosquitoes
Total number of recovered mosquito
hen the mortality effect (expressed in percentage) was
etermined:
ortality effect = 100 × mortality rate in treated dog
1 − mortality ra
he percentage of A. aegypti engorged females and live
emales in both groups were compared using a date-by-
ate analysis of variance followed by a non-parametric test
f Kruskall–Wallis. Differences were considered signiﬁcant
t P < 0.05. The analyses were performed with Systat 9 soft-
are using percentage ×10 as data.
. Results
All dogs included in the study demonstrated adequate
re-treatment parasite holding ability. On day −7, the per-
entage of engorged female was, respectively, 87.6% for
he treated group and 86.3% for the control group. All
ntreated animals maintained adequate engorged female
evel throughout the study (Fig. 1). Post-treatment per-
entage of engorged mosquitoes for the treated dogs was
igniﬁcantly lower than that for untreated control dogs
which ranged from 81% to 92% at all post-treatment eval-
ations – P < 0.05, Table 1). The treatment provided 91.5%
nti-feeding efﬁcacy on day 1 then ≥94% efﬁcacy up to 3
eeks after treatment (day 21) and at the end of the study
day 28) 87% efﬁcacy.
There was no signiﬁcant statistical difference between
oth groups in mortality in females at day −6 and at day −5
eaning that pre-treatment, blood feeding on dogs from
oth groups did not lead to death of mosquitoes. Then,
fter 1 h of exposure and 24 h after each challenge point
erformed at day 1, day 7, day 14, day 21 and day 28, the dif-
erence in mortality of females A. aegypti between treated
nd controlled group was signiﬁcant (P < 0.05).
The treatment had a mortality effect calculated at 1 h
nd at 24 h post-exposure above 93.0% and 93.4%, respec-
ively, until the end of the animal phase. The maximum
f mortality is obtained at day 7 with an efﬁcacy of 100%,
nd then remained above 96.3% until day 21. The mortal-
ty effect calculated at 1 h and at 24 h post-treatment was
pproximately the same (Table 1).logy 189 (2012) 333– 337 335
s
 − anti-feeding rate in untreated dogs
ate in untreated dogs
rtality rate in untreated dogs
 untreated dogs
3. Discussion
The objectives of this study were to evaluate the
insecticidal effect and the repellent effect of a formula-
tion with permethrin 36.08% (w/w), dinotefuran 4.95%
(w/w) and pyriproxyfen 0.44% (w/w) combination against
A. aegypti mosquitoes on dogs. This formulation pro-
vided excellent results with a good repellent effect – 94%
and insecticidal effect – 96% for 3 weeks post-treatment
falling to 87% in week 4. The treatment of dogs with
permethrin–dinotefuran–pyriproxyfen formulation seems
to offer better protection from Aedes mosquito bites than
formulations of lower or similar dosage of permethrin com-
bined with imidacloprid or with permethrin alone. Indeed,
in similar trials performed with A. aegypti (Meyer et al.,
2003; Tiawsirisup et al., 2007), insecticide efﬁcacy for 65%
permethrin alone ranged from 84% to 90.9% until day 21
and declined to 50.3% on day 28; insecticide efﬁcacy for
50% permethrin combined with 10% imidacloprid ranged
from 40.4% to 100% until day 21 and declined to 2.1% on
day 28. The permethrin–dinotefuran–pyriproxyfen combi-
nation provided an insecticide efﬁcacy between 93% (day
28) and 100% (day 7). The repellent effect obtained with
permethrin alone ranged from 78% to 89.9% through day
21 and declined to 61.9% on day 28; for treatment com-
bining imidacloprid and permethrin, the repellent effect
ranged from 84.9% to 94.1% through day 21 and declined
to 50.4% on day 28. The formulation tested in the current
study offered a repellent effect ranging from 91.5% to 94.7%
with minimal decline to 87% on day 28.
A. aegypti mosquitoes were chosen in this trial because
of their medical importance in transmission of the yellow
fever virus and other arboviruses and as a well-known vec-
tor of diroﬁlariosis which causes severe diseases and even
death in dogs in many parts of the world (McCall et al.,
2008). In addition, human beings can be affected by D.
immitis and D. repens although they are dead-end hosts for
these parasites (Estran et al., 2007; Genchi et al., 2011).The experimental protocol proposed here tended to
recreate natural infestation of dogs because mosquitoes
were allowed to bite on their preferential sites (around
eyes, around mouth and ventral part of the dog), as the full
336 M. Franc et al. / Veterinary Parasitology 189 (2012) 333– 337
0
10
20
30
40
50
60
70
80
90
100
D28D21D14D7D1D-6
Stud y days ( D0= Treatment day)
M
e
a
n
 n
u
m
b
e
r 
o
f 
e
n
g
o
re
d
 A
e
d
e
s
Group  A (Treated group )
Group  B ( control group )
Fig. 1. Evolution of mean number of engorged Aedes aegypti obtained in both groups after 1 h exposure to dogs.
Table 1
Mortality and antifeeding effect.
Day 1 (%) Day 7 (%) Day 14 (%) Day 21 (%) Day 28 (%)
Mortality effect
1 h 99.0a 100.0 96.3 98.9 93.0
24  h 98.9a 100.0 96.5 99.1 93.4
fter the Antifeeding effect (P-value)
1 h 91.5(0.004) 94.0(0.004)
a The mortality of A. aegypti in the control group during the 24 hours a
body of dogs was accessible. On the contrary, Tiawsirisup
et al. (2007) presented A. aegypti trapped in plastic cups to
dogs. The feeding rate they obtained in the control group
ranged from 49.4% to 88% versus a feeding rate from 86.3%
to 91.6% for the control group obtained in this current trial.
These differences conﬁrm the importance of sticking to
natural conditions of infestation. Furthermore, mosquitoes
were allowed to perform their entire blood meal without
any disturbance or interruption as the dogs were asleep.
Once the blood meal was performed, female mosquitoes
left the dogs to lay on the side of the net which made it eas-
ier for their collection. Mosquitoes in contact with treated
dogs died quickly after their exposure, especially on the
early days post-treatment (cf. day 7 with insecticidal effect
of 100%). This was conﬁrmed by the insecticide effect which
did not increase signiﬁcantly 24 h after exposure.
Recently, an increasing number of veterinarians
reported pet owners claiming that numerous parasiticide
products were not efﬁcient any more (Dryden et al., 2011)
against ectoparasites of pets. Resistance is often cited.
So the combination of new products or combination of
well-known products with new chemistries which have
not been associated yet could be a pertinent solution.
Murphy et al. (2009) demonstrated that dinotefuran was
more efﬁcient than imidacloprid against Ctenocephalides
felis on cats. In an assay against mosquitoes (Corbel
et al., 2004), dinotefuran was less toxic than most of the
commonly used insecticides (e.g., deltamethrin, carbosul-
fan and temephos); however, the efﬁcacy of dinotefuran
towards resistant mosquitoes was not strongly affected
by the presence of common resistance mechanisms
(kdr mutation and insensitive acetylcholinesterase). The94.0(0.004) 94.0(0.004) 87.0(0.004)
dog exposition explain the decrease of the mortality effect.
difference of sites of action of dinotefuran, acetylcholine
receptor versus sodium channels for pyrethroids, may
explain the absence of cross-resistance with common par-
asiticides and makes dinotefuran a potential candidate for
vector control in areas where mosquitoes may  be resistant
to common insecticides (Corbel et al., 2004).
Pyriproxifen, dinotefuran and permethrin are associ-
ated for the ﬁrst time in a formulation. The interest of this
association would be to broaden the spectrum of action to
ﬂeas and immature stages of ﬂeas which could be very use-
ful for dogs infested with ﬂeas travelling in endemic areas
of diroﬁlariosis, but this was not the aim for the current
study which chose to focus on its efﬁcacy towards A. aegypti
mosquitoes only.
In conclusion, the combination of permethrin–
dinotefuran–pyriproxyfen can be used on dogs to repel and
kill A. aegypti mosquitoes reducing stress and annoyance
caused by the bite of mosquitoes. More importantly, this
combination may  reduce the risk of heartworm transmis-
sion for animals leaving or travelling in Diroﬁlaria endemic
areas. The application of this combination needs to be
repeated every 3–4 weeks and it should not be seen as a
substitute for heartworm prevention treatments.
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